Biohit strikes Dx supply deal with Hefei Medicine

05/17/2013 | GenomeWeb Daily News (free registration)

Biohit, a biotech company based in Finland, has tapped Hefei Medicine to distribute its diagnostic products in China for undisclosed terms. The deal covers products such as the GastroPanel system, a blood-based biomarker assay used to detect Helicobacter pylori.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ